InvestorsHub Logo
Followers 0
Posts 183
Boards Moderated 0
Alias Born 02/15/2020

Re: None

Friday, 03/06/2020 10:17:38 AM

Friday, March 06, 2020 10:17:38 AM

Post# of 40501
“We immediately began preclinical testing and small-scale manufacture and have already shared robust preclinical data with our public and private partners,” Kim said in a statement. “We plan to begin human clinical trials in the U.S. in April and soon thereafter in China and South Korea, where the outbreak is impacting the most people.”

Maxim analyst Jason McCarthy, Ph.D., said Inovio likely has the best vaccine option for the new illness. The speed with which it developed INO-4800 “is demonstration of the versatility and speed with which Inovio can respond to an ‘emergency’ situation.”
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent INO News